66 related articles for article (PubMed ID: 38541090)
21. Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention.
Calabrò GE; Riccardi MT; D'Ambrosio F; Castagna C; Sapienza M; Millevolte R; Pellacchia A; Ricciardi R; de Vincenzo RP; de Waure C
Front Public Health; 2022; 10():1010237. PubMed ID: 36530690
[TBL] [Abstract][Full Text] [Related]
22. The epidermal immune microenvironment plays a dominant role in psoriasis development, as revealed by mass cytometry.
Zhou Y; Xu F; Chen XY; Yan BX; Wang ZY; Chen SQ; Zheng M; Man XY
Cell Mol Immunol; 2022 Dec; 19(12):1400-1413. PubMed ID: 36348078
[TBL] [Abstract][Full Text] [Related]
23. Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.
Bayik D; Bartels CF; Lovrenert K; Watson DC; Zhang D; Kay K; Lee J; Lauko A; Johnson S; Lo A; Silver DJ; McGraw M; Grabowski M; Mohammadi AM; Veglia F; Fan Y; Vogelbaum MA; Scacheri P; Lathia JD
Cancer Res; 2022 Nov; 82(22):4274-4287. PubMed ID: 36126163
[TBL] [Abstract][Full Text] [Related]
24. CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells.
Liang Y; Zhou X; Xie Q; Sun H; Huang K; Chen H; Wang W; Zhou B; Wei X; Zeng D; Lin H
Cancer Lett; 2022 Oct; 546():215856. PubMed ID: 35944750
[TBL] [Abstract][Full Text] [Related]
25.
Riemma G; Schettino MT; Munno GM; Fasulo DD; Sandullo L; Amabile E; La Verde M; Torella M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630063
[No Abstract] [Full Text] [Related]
26. Options for triage and implications for colposcopists within European HPV-based cervical screening programmes.
Leeson S; Alalade R; Singh N; Nieminen P; Cruickshank M; Carcopino X; Bergeron C
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():332-342. PubMed ID: 33524777
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.
Rotman J; den Otter LAS; Bleeker MCG; Samuels SS; Heeren AM; Roemer MGM; Kenter GG; Zijlmans HJMAA; van Trommel NE; de Gruijl TD; Jordanova ES
Front Immunol; 2020; 11():596825. PubMed ID: 33424844
[TBL] [Abstract][Full Text] [Related]
28. HPV post-infection microenvironment and cervical cancer.
Yuan Y; Cai X; Shen F; Ma F
Cancer Lett; 2021 Jan; 497():243-254. PubMed ID: 33122098
[TBL] [Abstract][Full Text] [Related]
29. Flow Cytometry Characterization of Pluripotent Transmembrane Glycoproteins on Resident Cervix Uteri Cells in Patients Screened for Cervical Cancer.
Colacurci N; Schettino MT; Grimaldi V; De Luca FP; Mansueto G; Costa D; Cacciatore F; De Franciscis P; Napoli C
Cancer Invest; 2020 Apr; 38(4):228-239. PubMed ID: 32208057
[TBL] [Abstract][Full Text] [Related]
30. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
Maver PJ; Poljak M
Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
[TBL] [Abstract][Full Text] [Related]
31. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
Berraho M; Amarti-Riffi A; El-Mzibri M; Bezad R; Benjaafar N; Benideer A; Matar N; Qmichou Z; Abda N; Attaleb M; Znati K; El Fatemi H; Bendahhou K; Obtel M; Filali Adib A; Mathoulin-Pelissier S; Nejjari C
BMC Cancer; 2017 Jun; 17(1):435. PubMed ID: 28633667
[TBL] [Abstract][Full Text] [Related]
32. Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.
Heeren AM; Punt S; Bleeker MC; Gaarenstroom KN; van der Velden J; Kenter GG; de Gruijl TD; Jordanova ES
Mod Pathol; 2016 Jul; 29(7):753-63. PubMed ID: 27056074
[TBL] [Abstract][Full Text] [Related]
33. Tumour exosome integrins determine organotropic metastasis.
Hoshino A; Costa-Silva B; Shen TL; Rodrigues G; Hashimoto A; Tesic Mark M; Molina H; Kohsaka S; Di Giannatale A; Ceder S; Singh S; Williams C; Soplop N; Uryu K; Pharmer L; King T; Bojmar L; Davies AE; Ararso Y; Zhang T; Zhang H; Hernandez J; Weiss JM; Dumont-Cole VD; Kramer K; Wexler LH; Narendran A; Schwartz GK; Healey JH; Sandstrom P; Labori KJ; Kure EH; Grandgenett PM; Hollingsworth MA; de Sousa M; Kaur S; Jain M; Mallya K; Batra SK; Jarnagin WR; Brady MS; Fodstad O; Muller V; Pantel K; Minn AJ; Bissell MJ; Garcia BA; Kang Y; Rajasekhar VK; Ghajar CM; Matei I; Peinado H; Bromberg J; Lyden D
Nature; 2015 Nov; 527(7578):329-35. PubMed ID: 26524530
[TBL] [Abstract][Full Text] [Related]
34. Expression of integrin β1 and its significance in squamous cell carcinoma of the cervix.
Zhan P; Liu L; Liu B; Mao XG
Mol Med Rep; 2014 Jun; 9(6):2473-8. PubMed ID: 24718718
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Ronco G; Dillner J; Elfström KM; Tunesi S; Snijders PJ; Arbyn M; Kitchener H; Segnan N; Gilham C; Giorgi-Rossi P; Berkhof J; Peto J; Meijer CJ;
Lancet; 2014 Feb; 383(9916):524-32. PubMed ID: 24192252
[TBL] [Abstract][Full Text] [Related]
36. A conserved C-terminal sequence of high-risk cutaneous beta-human papillomavirus E6 proteins alters localization and signalling of β1-integrin to promote cell migration.
Holloway A; Storey A
J Gen Virol; 2014 Jan; 95(Pt 1):123-134. PubMed ID: 24154967
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors.
Daves MH; Hilsenbeck SG; Lau CC; Man TK
BMC Med Genomics; 2011 Jul; 4():56. PubMed ID: 21736749
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
39. Integrins and mutant p53 on the road to metastasis.
Selivanova G; Ivaska J
Cell; 2009 Dec; 139(7):1220-2. PubMed ID: 20064366
[TBL] [Abstract][Full Text] [Related]
40. Integrins in cancer: biological implications and therapeutic opportunities.
Desgrosellier JS; Cheresh DA
Nat Rev Cancer; 2010 Jan; 10(1):9-22. PubMed ID: 20029421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
